世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
細胞培養市場：製品（消耗品（培地、血清、試薬、容器）、装置（バイオリアクター、遠心分離機、インキュベーター））、用途（ワクチン、mAb、診断薬、組織工学）、エンドユーザー（製薬、バイオテクノロジー、病院）-2026年までの世界市場予測Cell Culture Market by Product (Consumables (Media, Serum, Reagent, Vessels), Equipment (Bioreactor, Centrifuge, Incubator)), Application (Vaccines, mAbs, Diagnostics, Tissue Engineering), End User (Pharma, Biotech, Hospital) - Global Forecast to 2026 細胞培養の世界市場は、2021年の228億米ドルから2026年には413億米ドルに達すると予測され、2021年から2026年の間に12.6%のCAGR（平均成長率）が見込まれています。この市場の成長は、細胞ベースのワクチンの利点... もっと見る
日本語のページは自動翻訳を利用し作成しています。 
サマリー細胞培養の世界市場は、2021年の228億米ドルから2026年には413億米ドルに達すると予測され、2021年から2026年の間に12.6%のCAGR（平均成長率）が見込まれています。この市場の成長は、細胞ベースのワクチンの利点に関する意識の高まり、モノクローナル抗体（mAbs）の需要の増加、細胞ベースの研究への資金提供、シングルユース技術への好みの高まり、高度な細胞培養製品の発売、個別化医療への注目の高まりが主な要因となっています。一方、細胞生物学研究にかかるコストの高さが、この市場の成長を抑制しています。"予測期間中の細胞培養市場において、製品別では消耗品セグメントが最も高い成長率を占めた" 2020年では、消耗品分野が最も高い成長率を占めている。細胞培養用消耗品は、血清・培地・試薬、容器、アクセサリーに区分される。細胞培養用消耗品市場では、血清・培地・試薬分野が最大のシェアを占めると予想されます。このセグメントの大きなシェアは、様々な細胞培養アプリケーションのために、血清、培地、試薬を繰り返し大量に購入し、必要とすることに起因しています。サーモフィッシャーサイエンティフィック社(米国）、Merck KGaA（ドイツ）、Danaher Corporation（米国）、Corning Incorporated（米国）、Eppendorf AG（ドイツ）、Fujifilm Irvine Scientific, Inc.(日本）、Lonza Group AG（スイス）、Sartorius AG（ドイツ）、Agilent Technologies, Inc.(米国）、Getinge AB（スウェーデン）、Becton, Dickinson and Company（米国）、Miltenyi Biotec（ドイツ）、HiMedia Laboratories（インド）などが、細胞培養市場で事業を展開している主要企業である。 "アジア太平洋地域細胞培養市場で最も成長率の高い地域" 細胞培養市場は、北米、欧州、アジア太平洋地域、中南米（LATAM）、中東・アフリカ（MEA）に区分されます。アジア太平洋地域は、予測期間中に14.0%という最も高いCAGRを記録すると推定されます。幹細胞治療の研究に対する政府の取り組み、老年人口の増加、再生医療研究の隆盛、日本における研究者の増加、中国における前臨床/臨床研究の成長、インドにおける医薬品産業への外国直接投資（FDI）規制の有利な変更、韓国における医薬品・バイオ医薬品分野の成長が、アジア太平洋地域の細胞培養市場の成長に寄与する主因となっています。 本レポートのために実施した一次インタビューは、以下のように分類される。 - 回答者別供給側80％、需要側20 - 職位別Cレベル：45％、Dレベル：30％、その他：25 - 地域別北米 -20%、欧州 -10%、アジア太平洋 -55%、中南米 -10%、中東・アフリカ -5%。 報告書に掲載された企業一覧 - サーモフィッシャーサイエンティフィック（Thermo Fisher Scientific Inc.(米国) - メルクKGaA（ドイツ） - ダナハーコーポレーション（米国） - コーニング・インコーポレイテッド（米国） - エッペンドルフAG（ドイツ） - 富士フイルムアーバインサイエンティフィック株式会社(日本) - ロンザグループAG（スイス） - ザルトリウスAG（ドイツ） - アジレント・テクノロジー株式会社（Agilent Technologies, Inc.(米国) - ゲティンゲAB（スウェーデン） - ベクトン・ディッキンソン アンド カンパニー（米国） - Miltenyi Biotec（ドイツ） - ハイメディアラボラトリーズ（インド） - STEMCELL Technologies Inc.(カナダ) - ソリダバイオテック社（ドイツ） - カイソンラボラトリーズInc.(アメリカ) - プロモセルGmbH（ドイツ） - インビボジェン社（米国） - パンバイオテック社（ドイツ） - Cellexus社（英国） - マイスナー・フィルトレーション・プロダクツ社(米国) - アドルフ・キューナーAG（スイス） - セラケアライフサイエンス株式会社(米国) - ANGUS Chemical Company (米国) - バイオスフェリックス社(米国) 調査対象 本レポートは、細胞培養市場の詳細なイメージを提供します。製品、アプリケーション、エンドユーザー、地域などの異なるセグメントにおける市場規模と今後の成長性を推定することを目的としています。また、主要な市場プレイヤーの企業プロファイルや最近の開発状況、主要な市場戦略とともに、詳細な競合分析も行っています。 レポート購入の主なメリット 本レポートは、細胞培養市場全体とそのサブセグメントに関する収益数の最も近い概算を提供することにより、市場リーダー/新規参入者を支援します。また、利害関係者が競争環境をより良く理解し、より良いビジネスの位置付けと適切な市場参入戦略を立てるためのより多くの洞察を得るのに役立ちます。本レポートは、利害関係者が市場の脈動を理解し、主要な市場促進要因、阻害要因、課題、トレンド、機会に関する情報を提供することを可能にします。
SummaryThe global cell culture market is projected to USD 41.3 billion by 2026 from USD 22.8 billion in 2021, at a CAGR of 12.6 % between 2021 and 2026. The growth of this market is majorly driven by the growing awareness about the benefits of cell-based vaccines, increasing demand for monoclonal antibodies (mAbs), funding for cell-based research, growing preference for single-use technologies, the launch of advanced cell culture products, and the growing focus on personalized medicine. On the other hand, the high cost of cell biology research is restraining the growth of this market. Table of Contents
1 INTRODUCTION 67
1.1 OBJECTIVES OF THE STUDY 67
1.2 MARKET DEFINITION 67
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 68
1.3 MARKET SCOPE 69
1.3.1 MARKETS COVERED 69
1.3.2 YEARS CONSIDERED FOR THE STUDY 70
1.4 CURRENCY 70
1.5 LIMITATIONS 70
1.6 STAKEHOLDERS 71
1.7 SUMMARY OF CHANGES 71
2 RESEARCH METHODOLOGY 73
2.1 RESEARCH DATA 73
FIGURE 1 RESEARCH DESIGN 73
2.1.1 SECONDARY DATA 74
2.1.2 PRIMARY DATA 75
FIGURE 2 BREAKDOWN OF PRIMARIES: CELL CULTURE MARKET 75
2.2 MARKET ESTIMATION METHODOLOGY 76
FIGURE 3 CELL CULTURE MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2020 76
FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE
ANALYSIS-BASED ESTIMATION), 2020 76
2.2.1 INSIGHTS FROM PRIMARY EXPERTS 77
FIGURE 5 MARKET SIZE VALIDATION FROM PRIMARY SOURCES 77
2.3 MARKET GROWTH RATE PROJECTIONS 78
FIGURE 6 CELL CULTURE MARKET (SUPPLY-SIDE): CAGR PROJECTIONS 79
FIGURE 7 CELL CULTURE MARKET (DEMAND-SIDE): GROWTH ANALYSIS
OF DEMAND-SIDE FACTORS 79
2.4 DATA TRIANGULATION 80
FIGURE 8 DATA TRIANGULATION METHODOLOGY 80
2.5 RESEARCH ASSUMPTIONS 80
2.5.1 COVID-19-SPECIFIC ASSUMPTIONS 81
2.6 RISK ANALYSIS 81
3 EXECUTIVE SUMMARY 82
FIGURE 9 CELL CULTURE MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION) 82
FIGURE 10 CELL CULTURE MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION) 83
FIGURE 11 CELL CULTURE MARKET, BY END USER, 2021 VS. 2026 (USD MILLION) 84
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THE CELL CULTURE MARKET 85
4 PREMIUM INSIGHTS 86
4.1 CELL CULTURE MARKET OVERVIEW 86
FIGURE 13 GROWING AWARENESS ABOUT THE BENEFITS OF CELL-BASED VACCINES AND LAUNCH OF ADVANCED CELL CULTURE PRODUCTS TO DRIVE
MARKET GROWTH 86
4.2 NORTH AMERICA: CELL CULTURE MARKET, BY PRODUCT AND COUNTRY (2020) 87
FIGURE 14 CONSUMABLES SEGMENT ACCOUNTED FOR THE LARGEST SHARE
OF THE NORTH AMERICAN CELL CULTURE MARKET IN 2020 87
4.3 CELL CULTURE MARKET SHARE, BY APPLICATION, 2021 VS. 2026 87
FIGURE 15 BIOPHARMACEUTICAL PRODUCTION SEGMENT WILL CONTINUE TO DOMINATE THE MARKET IN 2026 87
4.4 CELL CULTURE MARKET SHARE, BY END USER, 2020 88
FIGURE 16 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES DOMINATED
THE MARKET IN 2020 88
4.5 CELL CULTURE MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 88
FIGURE 17 ASIA PACIFIC COUNTRIES TO REGISTER THE HIGHEST GROWTH RATE
FROM 2021 TO 2026 88
5 MARKET OVERVIEW 89
5.1 INTRODUCTION 89
5.2 MARKET DYNAMICS 89
FIGURE 18 CELL CULTURE MARKET: DRIVERS, RESTRAINT, OPPORTUNITIES,
AND CHALLENGES 89
TABLE 1 CELL CULTURE MARKET: IMPACT ANALYSIS 90
5.2.1 DRIVERS 90
5.2.1.1 Growing awareness about the benefits of cell-based vaccines 90
TABLE 2 APPROVED CELL CULTURE-BASED VACCINES FOR INFLUENZA 91
5.2.1.2 Increasing demand for monoclonal antibodies 91
TABLE 3 APPROVED MONOCLONAL ANTIBODIES FOR THERAPEUTIC USE
BY US FDA (2018–2020) 92
5.2.1.3 Funding for cell-based research 93
5.2.1.4 Growing preference for single-use technologies 93
FIGURE 19 ADOPTION OF SINGLE-USE PRODUCTS IN BIOPHARMACEUTICAL MANUFACTURING, 2019 94
5.2.1.5 Launch of advanced cell culture products 94
5.2.1.6 Growing focus on personalized medicine 95
TABLE 4 GROWTH IN THE NUMBER OF PERSONALIZED MEDICINES 95
FIGURE 20 GROWING NUMBER OF FDA APPROVALS FOR PERSONALIZED MEDICINES 95
5.2.2 RESTRAINTS 96
5.2.2.1 High cost of cell biology research 96
5.2.2.2 Limitations in the production of high-density cell cultures 96
5.2.3 OPPORTUNITIES 97
5.2.3.1 Growing demand for 3D cell culture 97
5.2.3.2 Growing risk of pandemics and communicable diseases 97
5.2.3.3 Emerging economies 98
5.2.4 CHALLENGES 99
5.2.4.1 Plastic waste disposal 99
TABLE 5 COMPARISON OF SINGLE-USE BIOPROCESSING SYSTEM DISPOSAL OPTIONS 99
5.3 RANGES/SCENARIOS 100
FIGURE 21 SPECTRUM OF SCENARIOS BASED ON THE IMPACT OF UNCERTAINTIES
ON THE GROWTH OF THE CELL CULTURE MARKET 100
5.4 IMPACT OF THE COVID-19 OUTBREAK ON THE CELL CULTURE MARKET 100
FIGURE 22 CELL CULTURE MARKET SCENARIO WITH AND WITHOUT
COVID-19 IMPACT, 2019–2021 101
5.5 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 102
5.6 PRICING ANALYSIS 103
TABLE 6 AVERAGE SELLING PRICE OF SINGLE-USE BIOREACTORS, BY REGION (2019) 103
5.7 TECHNOLOGY ANALYSIS 103
TABLE 7 ADVANTAGES OF SINGLE-USE BIOREACTORS AND STAINLESS-STEEL BIOREACTORS 104
5.8 PATENT ANALYSIS 105
FIGURE 23 PATENT APPLICATIONS FOR THE CELL CULTURE MARKET,
JANUARY 2011–DECEMBER 2021 105
TABLE 8 INDICATIVE LIST OF PATENTS IN THE CELL CULTURE MARKET 105
5.9 VALUE CHAIN ANALYSIS 107
FIGURE 24 VALUE CHAIN ANALYSIS OF THE CELL CULTURE MARKET: RAW MATERIAL
AND MANUFACTURING PHASE CONTRIBUTES MAXIMUM VALUE 107
5.10 SUPPLY CHAIN ANALYSIS 108
FIGURE 25 CELL CULTURE MARKET: SUPPLY CHAIN ANALYSIS 109
5.11 ECOSYSTEM ANALYSIS OF THE CELL CULTURE MARKET 109
TABLE 9 SUPPLY CHAIN ECOSYSTEM 110
5.12 PORTER’S FIVE FORCES ANALYSIS 111
TABLE 10 CELL CULTURE MARKET: PORTER’S FIVE FORCES ANALYSIS 111
5.12.1 THREAT OF NEW ENTRANTS 112
5.12.2 THREAT OF SUBSTITUTES 112
5.12.3 BARGAINING POWER OF SUPPLIERS 112
5.12.4 BARGAINING POWER OF BUYERS 112
5.13 REGULATORY ANALYSIS 113
5.13.1 US 113
5.13.2 EUROPE 114
6 CELL CULTURE MARKET, BY PRODUCT 115
6.1 INTRODUCTION 116
TABLE 11 CELL CULTURE MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 116
6.2 CONSUMABLES 116
TABLE 12 CELL CULTURE CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 116
TABLE 13 CELL CULTURE CONSUMABLES MARKET, BY REGION,
2019–2026 (USD MILLION) 117
TABLE 14 NORTH AMERICA: CELL CULTURE CONSUMABLES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 117
TABLE 15 EUROPE: CELL CULTURE CONSUMABLES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 117
TABLE 16 ASIA PACIFIC: CELL CULTURE CONSUMABLES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 118
TABLE 17 LATIN AMERICA: CELL CULTURE CONSUMABLES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 118
6.2.1 SERA, MEDIA, AND REAGENTS 118
TABLE 18 SERA, MEDIA, AND REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 119
TABLE 19 SERA, MEDIA, AND REAGENTS MARKET, BY REGION,
2019–2026 (USD MILLION) 119
TABLE 20 NORTH AMERICA: SERA, MEDIA, AND REAGENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 119
TABLE 21 EUROPE: SERA, MEDIA, AND REAGENTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 120
TABLE 22 ASIA PACIFIC: SERA, MEDIA, AND REAGENTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 120
TABLE 23 LATIN AMERICA: SERA, MEDIA, AND REAGENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 120
6.2.2 MEDIA 121
TABLE 24 CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION) 121
TABLE 25 CELL CULTURE MEDIA MARKET, BY REGION, 2019–2026 (USD MILLION) 122
TABLE 26 NORTH AMERICA: CELL CULTURE MEDIA MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 122
TABLE 27 EUROPE: CELL CULTURE MEDIA MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 122
TABLE 28 ASIA PACIFIC: CELL CULTURE MEDIA MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 123
TABLE 29 LATIN AMERICA: CELL CULTURE MEDIA MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 123
6.2.2.1 Serum-free media 123
6.2.2.1.1 Lack of sera eliminates the risk of contamination 123
TABLE 30 SERUM-FREE MEDIA OFFERED BY KEY MARKET PLAYERS 124
TABLE 31 SERUM-FREE MEDIA MARKET, BY REGION, 2019–2026 (USD MILLION) 124
TABLE 32 NORTH AMERICA: SERUM-FREE MEDIA MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 125
TABLE 33 EUROPE: SERUM-FREE MEDIA MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 125
TABLE 34 ASIA PACIFIC: SERUM-FREE MEDIA MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 125
TABLE 35 LATIN AMERICA: SERUM-FREE MEDIA MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 126
6.2.2.2 Classical media & salts 126
6.2.2.2.1 Classical media is commonly used in virology, vaccine production, and primary tissue explant culture 126
TABLE 36 CLASSICAL MEDIA & SALTS OFFERED BY KEY MARKET PLAYERS 126
TABLE 37 CLASSICAL MEDIA & SALTS MARKET, BY REGION,
2019–2026 (USD MILLION) 127
TABLE 38 NORTH AMERICA: CLASSICAL MEDIA & SALTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 128
TABLE 39 EUROPE: CLASSICAL MEDIA & SALTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 128
TABLE 40 ASIA PACIFIC: CLASSICAL MEDIA & SALTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 128
TABLE 41 LATIN AMERICA: CLASSICAL MEDIA & SALTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 129
6.2.2.3 Stem cell culture media 129
6.2.2.3.1 Stem cell culture media to witness the highest growth
in the APAC market during the forecast period 129
TABLE 42 STEM CELL CULTURE MEDIA OFFERED BY KEY MARKET PLAYERS 129
TABLE 43 STEM CELL CULTURE MEDIA MARKET, BY REGION,
2019–2026 (USD MILLION) 130
TABLE 44 NORTH AMERICA: STEM CELL CULTURE MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 130
TABLE 45 EUROPE: STEM CELL CULTURE MEDIA MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 131
TABLE 46 ASIA PACIFIC: STEM CELL CULTURE MEDIA MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 131
TABLE 47 LATIN AMERICA: STEM CELL CULTURE MEDIA MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 131
6.2.2.4 Chemically defined (CD) media 132
6.2.2.4.1 Chemically defined media helps reduce process costs and increase product yield 132
TABLE 48 CHEMICALLY DEFINED MEDIA OFFERED BY KEY MARKET PLAYERS 132
TABLE 49 CHEMICALLY DEFINED MEDIA MARKET, BY REGION,
2019–2026 (USD MILLION) 132
TABLE 50 NORTH AMERICA: CHEMICALLY DEFINED MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 133
TABLE 51 EUROPE: CHEMICALLY DEFINED MEDIA MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 133
TABLE 52 ASIA PACIFIC: CHEMICALLY DEFINED MEDIA MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 133
TABLE 53 LATIN AMERICA: CHEMICALLY DEFINED MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 134
6.2.2.5 Specialty media 134
6.2.2.5.1 Specialty media is suitable for the growth of
selective cell types 134
TABLE 54 SPECIALTY MEDIA OFFERED BY KEY MARKET PLAYERS 134
TABLE 55 SPECIALTY MEDIA MARKET, BY REGION, 2019–2026 (USD MILLION) 135
TABLE 56 NORTH AMERICA: SPECIALTY MEDIA MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 135
TABLE 57 EUROPE: SPECIALTY MEDIA MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 136
TABLE 58 ASIA PACIFIC: SPECIALTY MEDIA MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 136
TABLE 59 LATIN AMERICA: SPECIALTY MEDIA MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 136
6.2.2.6 Other media 137
TABLE 60 OTHER MEDIA OFFERED BY KEY MARKET PLAYERS 137
TABLE 61 OTHER MEDIA MARKET, BY REGION, 2019–2026 (USD MILLION) 138
TABLE 62 NORTH AMERICA: OTHER MEDIA MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 138
TABLE 63 EUROPE: OTHER MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 138
TABLE 64 ASIA PACIFIC: OTHER MEDIA MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 139
TABLE 65 LATIN AMERICA: OTHER MEDIA MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 139
6.2.3 REAGENTS 139
TABLE 66 CELL CULTURE REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 140
TABLE 67 CELL CULTURE REAGENTS MARKET, BY REGION, 2019–2026 (USD MILLION) 140
TABLE 68 NORTH AMERICA: CELL CULTURE REAGENTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 141
TABLE 69 EUROPE: CELL CULTURE REAGENTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 141
TABLE 70 ASIA PACIFIC: CELL CULTURE REAGENTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 141
TABLE 71 LATIN AMERICA: CELL CULTURE REAGENTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 142
6.2.3.1 Growth factors 142
6.2.3.1.1 Growth factors are unique cell signaling molecules that help in cell proliferation & development 142
TABLE 72 GROWTH FACTORS MARKET, BY REGION, 2019–2026 (USD MILLION) 142
TABLE 73 NORTH AMERICA: GROWTH FACTORS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 143
TABLE 74 EUROPE: GROWTH FACTORS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 143
TABLE 75 ASIA PACIFIC: GROWTH FACTORS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 143
TABLE 76 LATIN AMERICA: GROWTH FACTORS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 144
6.2.3.2 Supplements 144
6.2.3.2.1 Supplements such as amino acids and vitamins play a key role in inducing cell growth 144
TABLE 77 SUPPLEMENTS MARKET, BY REGION, 2019–2026 (USD MILLION) 144
TABLE 78 NORTH AMERICA: SUPPLEMENTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 145
TABLE 79 EUROPE: SUPPLEMENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 145
TABLE 80 ASIA PACIFIC: SUPPLEMENTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 145
TABLE 81 LATIN AMERICA: SUPPLEMENTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 146
6.2.3.3 Buffers & chemicals 146
6.2.3.3.1 Chemicals and buffers are widely used in cell culture but they can be toxic at higher concentrations 146
TABLE 82 BUFFERS & CHEMICALS MARKET, BY REGION, 2019–2026 (USD MILLION) 146
TABLE 83 NORTH AMERICA: BUFFERS & CHEMICALS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 147
TABLE 84 EUROPE: BUFFERS & CHEMICALS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 147
TABLE 85 ASIA PACIFIC: BUFFERS & CHEMICALS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 147
TABLE 86 LATIN AMERICA: BUFFERS & CHEMICALS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 148
6.2.3.4 Cell dissociation reagents 148
6.2.3.4.1 Dissociation reagents are vital for further
subculturing of cells 148
TABLE 87 CELL DISSOCIATION REAGENTS MARKET, BY REGION,
2019–2026 (USD MILLION) 149
TABLE 88 NORTH AMERICA: CELL DISSOCIATION REAGENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 149
TABLE 89 EUROPE: CELL DISSOCIATION REAGENTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 149
TABLE 90 ASIA PACIFIC: CELL DISSOCIATION REAGENTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 150
TABLE 91 LATIN AMERICA: CELL DISSOCIATION REAGENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 150
6.2.3.5 Balanced salt solutions 150
6.2.3.5.1 Balanced salt solutions are essential to maintain
osmotic balance in cells 150
TABLE 92 BALANCED SALT SOLUTIONS MARKET, BY REGION,
2019–2026 (USD MILLION) 151
TABLE 93 NORTH AMERICA: BALANCED SALT SOLUTIONS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 151
TABLE 94 EUROPE: BALANCED SALT SOLUTIONS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 151
TABLE 95 ASIA PACIFIC: BALANCED SALT SOLUTIONS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 152
TABLE 96 LATIN AMERICA: BALANCED SALT SOLUTIONS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 152
6.2.3.6 Attachment & matrix factors 152
6.2.3.6.1 The development of cells is dependent on
attachment factors 152
TABLE 97 ATTACHMENT & MATRIX FACTORS MARKET, BY REGION,
2019–2026 (USD MILLION) 153
TABLE 98 NORTH AMERICA: ATTACHMENT & MATRIX FACTORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 153
TABLE 99 EUROPE: ATTACHMENT & MATRIX FACTORS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 153
TABLE 100 ASIA PACIFIC: ATTACHMENT & MATRIX FACTORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 154
TABLE 101 LATIN AMERICA: ATTACHMENT & MATRIX FACTORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 154
6.2.3.7 Antibiotics/antimycotics 154
6.2.3.7.1 Contamination risk makes use of antibiotics/
antimycotics essential 154
TABLE 102 ANTIBIOTICS/ANTIMYCOTICS MARKET, BY REGION,
2019–2026 (USD MILLION) 155
TABLE 103 NORTH AMERICA: ANTIBIOTICS/ANTIMYCOTICS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 155
TABLE 104 EUROPE: ANTIBIOTICS/ANTIMYCOTICS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 155
TABLE 105 ASIA PACIFIC: ANTIBIOTICS/ANTIMYCOTICS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 156
TABLE 106 LATIN AMERICA: ANTIBIOTICS/ANTIMYCOTICS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 156
6.2.3.8 Cryoprotective reagents 156
6.2.3.8.1 Cryoprotective reagents protect tissues/cells from
damage due to freezing 156
TABLE 107 CRYOPROTECTIVE REAGENTS MARKET, BY REGION,
2019–2026 (USD MILLION) 157
TABLE 108 NORTH AMERICA: CRYOPROTECTIVE REAGENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 157
TABLE 109 EUROPE: CRYOPROTECTIVE REAGENTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 157
TABLE 110 ASIA PACIFIC: CRYOPROTECTIVE REAGENTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 158
TABLE 111 LATIN AMERICA: CRYOPROTECTIVE REAGENTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 158
6.2.3.9 Contamination detection kits 158
6.2.3.9.1 Contamination detection kits provide rapid results 158
TABLE 112 CONTAMINATION DETECTION KITS MARKET, BY REGION,
2019–2026 (USD MILLION) 159
TABLE 113 NORTH AMERICA: CONTAMINATION DETECTION KITS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 159
TABLE 114 EUROPE: CONTAMINATION DETECTION KITS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 159
TABLE 115 ASIA PACIFIC: CONTAMINATION DETECTION KITS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 160
TABLE 116 LATIN AMERICA: CONTAMINATION DETECTION KITS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 160
6.2.3.10 Other reagents 160
TABLE 117 OTHER REAGENTS MARKET, BY REGION, 2019–2026 (USD MILLION) 161
TABLE 118 NORTH AMERICA: OTHER REAGENTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 161
TABLE 119 EUROPE: OTHER REAGENTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 161
TABLE 120 ASIA PACIFIC: OTHER REAGENTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 162
TABLE 121 LATIN AMERICA: OTHER REAGENTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 162
6.2.4 SERA 162
TABLE 122 SERA MARKET, BY TYPE, 2019–2026 (USD MILLION) 163
TABLE 123 SERA MARKET, BY REGION, 2019–2026 (USD MILLION) 163
TABLE 124 NORTH AMERICA: SERA MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 163
TABLE 125 EUROPE: SERA MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 164
TABLE 126 ASIA PACIFIC: SERA MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 164
TABLE 127 LATIN AMERICA: SERA MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 164
6.2.4.1 Fetal bovine sera 165
6.2.4.1.1 Use of FBS is now restricted due to regulatory guidelines 165
TABLE 128 FETAL BOVINE SERA MARKET, BY REGION, 2019–2026 (USD MILLION) 165
TABLE 129 NORTH AMERICA: FETAL BOVINE SERA MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 165
TABLE 130 EUROPE: FETAL BOVINE SERA MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 166
TABLE 131 ASIA PACIFIC: FETAL BOVINE SERA MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 166
TABLE 132 LATIN AMERICA: FETAL BOVINE SERA MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 166
6.2.4.2 Adult bovine sera 167
6.2.4.2.1 ABS is a cost-effective alternative to FBS and is used
as a biochemical reagent in IVD 167
TABLE 133 ADULT BOVINE SERA MARKET, BY REGION, 2019–2026 (USD MILLION) 167
TABLE 134 NORTH AMERICA: ADULT BOVINE SERA MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 167
TABLE 135 EUROPE: ADULT BOVINE SERA MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 168
TABLE 136 ASIA PACIFIC: ADULT BOVINE SERA MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 168
TABLE 137 LATIN AMERICA: ADULT BOVINE SERA MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 168
6.2.4.3 Other animal sera 169
TABLE 138 OTHER ANIMAL SERA MARKET, BY REGION, 2019–2026 (USD MILLION) 169
TABLE 139 NORTH AMERICA: OTHER ANIMAL SERA MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 169
TABLE 140 EUROPE: OTHER ANIMAL SERA MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 170
TABLE 141 ASIA PACIFIC: OTHER ANIMAL SERA MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 170
TABLE 142 LATIN AMERICA: OTHER ANIMAL SERA MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 170
6.2.5 VESSELS 171
TABLE 143 VESSELS MARKET, BY TYPE, 2019–2026 (USD MILLION) 171
TABLE 144 VESSELS MARKET, BY REGION, 2019–2026 (USD MILLION) 171
TABLE 145 NORTH AMERICA: VESSELS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 171
TABLE 146 EUROPE: VESSELS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 172
TABLE 147 ASIA PACIFIC: VESSELS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 172
TABLE 148 LATIN AMERICA: VESSELS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 172
6.2.5.1 Roller/roux bottles 173
6.2.5.1.1 Roller bottles offer an economical means of cultivating large cell volumes 173
TABLE 149 ROLLER/ROUX BOTTLES MARKET, BY REGION, 2019–2026 (USD MILLION) 173
TABLE 150 NORTH AMERICA: ROLLER/ROUX BOTTLES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 173
TABLE 151 EUROPE: ROLLER/ROUX BOTTLES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 174
TABLE 152 ASIA PACIFIC: ROLLER/ROUX BOTTLES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 174
TABLE 153 LATIN AMERICA: ROLLER/ROUX BOTTLES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 174
6.2.5.1.2 Roller/roux bottles market, by application 175
TABLE 154 ROLLER/ROUX BOTTLES MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 175
6.2.5.2 Cell factory systems/cell stacks 175
6.2.5.2.1 Cell stacks require special handling equipment
and skilled expertise 175
TABLE 155 CELL FACTORY SYSTEMS/CELL STACKS MARKET, BY REGION,
2019–2026 (USD MILLION) 175
TABLE 156 NORTH AMERICA: CELL FACTORY SYSTEMS/CELL STACKS MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 176
TABLE 157 EUROPE: CELL FACTORY SYSTEMS/CELL STACKS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 176
TABLE 158 ASIA PACIFIC: CELL FACTORY SYSTEMS/CELL STACKS MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 176
TABLE 159 LATIN AMERICA: CELL FACTORY SYSTEMS/CELL STACKS MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 177
6.2.5.2.2 Cell factory systems/cell stacks market, by application 177
TABLE 160 CELL FACTORY SYSTEMS/CELL STACKS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 177
6.2.5.3 Multiwell plates 177
6.2.5.3.1 Multiwell plates help to run multiple tests parallelly 177
TABLE 161 MULTIWELL PLATES MARKET, BY REGION, 2019–2026 (USD MILLION) 178
TABLE 162 NORTH AMERICA: MULTIWELL PLATES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 178
TABLE 163 EUROPE: MULTIWELL PLATES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 178
TABLE 164 ASIA PACIFIC: MULTIWELL PLATES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 179
TABLE 165 LATIN AMERICA: MULTIWELL PLATES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 179
6.2.5.3.2 Multiwell plates market, by application 179
TABLE 166 MULTIWELL PLATES MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 179
6.2.5.4 Flasks 180
6.2.5.4.1 Disposable flasks are in greater demand among end users 180
TABLE 167 FLASKS MARKET, BY REGION, 2019–2026 (USD MILLION) 180
TABLE 168 NORTH AMERICA: FLASKS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 180
TABLE 169 EUROPE: FLASKS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 181
TABLE 170 ASIA PACIFIC: FLASKS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 181
TABLE 171 LATIN AMERICA: FLASKS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 181
6.2.5.4.2 Flasks market, by application 182
TABLE 172 FLASKS MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 182
6.2.5.5 Petri dishes 182
6.2.5.5.1 Wide usage of Petri dishes is attributed to their ease of use 182
TABLE 173 PETRI DISHES MARKET, BY REGION, 2019–2026 (USD MILLION) 182
TABLE 174 NORTH AMERICA: PETRI DISHES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 183
TABLE 175 EUROPE: PETRI DISHES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 183
TABLE 176 ASIA PACIFIC: PETRI DISHES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 183
TABLE 177 LATIN AMERICA: PETRI DISHES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 184
6.2.5.5.2 Petri dishes market, by application 184
TABLE 178 PETRI DISHES MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 184
6.2.6 ACCESSORIES 184
TABLE 179 ACCESSORIES MARKET, BY REGION, 2019–2026 (USD MILLION) 185
TABLE 180 NORTH AMERICA: ACCESSORIES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 185
TABLE 181 EUROPE: ACCESSORIES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 185
TABLE 182 ASIA PACIFIC: ACCESSORIES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 186
TABLE 183 LATIN AMERICA: ACCESSORIES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 186
6.3 EQUIPMENT 186
TABLE 184 CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION) 187
TABLE 185 CELL CULTURE EQUIPMENT MARKET, BY REGION,
2019–2026 (USD MILLION) 187
TABLE 186 NORTH AMERICA: CELL CULTURE EQUIPMENT MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 187
TABLE 187 EUROPE: CELL CULTURE EQUIPMENT MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 188
TABLE 188 ASIA PACIFIC: CELL CULTURE EQUIPMENT MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 188
TABLE 189 LATIN AMERICA: CELL CULTURE EQUIPMENT MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 188
6.3.1 SUPPORTING EQUIPMENT 189
TABLE 190 CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 189
TABLE 191 CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY REGION,
2019–2026 (USD MILLION) 189
TABLE 192 NORTH AMERICA: CELL CULTURE SUPPORTING EQUIPMENT MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 190
TABLE 193 EUROPE: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 190
TABLE 194 ASIA PACIFIC: CELL CULTURE SUPPORTING EQUIPMENT MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 190
TABLE 195 LATIN AMERICA: CELL CULTURE SUPPORTING EQUIPMENT MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 191
6.3.1.1 Filtration systems 191
6.3.1.1.1 Growing research activities in cell biology is a key factor driving market growth 191
TABLE 196 FILTRATION SYSTEMS OFFERED BY KEY MARKET PLAYERS 191
TABLE 197 FILTRATION SYSTEMS MARKET, BY REGION, 2019–2026 (USD MILLION) 192
TABLE 198 NORTH AMERICA: FILTRATION SYSTEMS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 192
TABLE 199 EUROPE: FILTRATION SYSTEMS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 192
TABLE 200 ASIA PACIFIC: FILTRATION SYSTEMS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 193
TABLE 201 LATIN AMERICA: FILTRATION SYSTEMS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 193
6.3.1.2 Cell counters 193
6.3.1.2.1 Automated cell counters are witnessing growing demand 193
TABLE 202 CELL COUNTERS OFFERED BY KEY MARKET PLAYERS 194
TABLE 203 CELL COUNTERS MARKET, BY REGION, 2019–2026 (USD MILLION) 194
TABLE 204 NORTH AMERICA: CELL COUNTERS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 194
TABLE 205 EUROPE: CELL COUNTERS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 195
TABLE 206 ASIA PACIFIC: CELL COUNTERS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 195
TABLE 207 LATIN AMERICA: CELL COUNTERS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 195
6.3.1.3 Carbon dioxide incubators 196
6.3.1.3.1 Incubators provide control over atmospheric conditions 196
TABLE 208 CARBON DIOXIDE INCUBATORS OFFERED BY KEY MARKET PLAYERS 196
TABLE 209 CARBON DIOXIDE INCUBATORS MARKET, BY REGION,
2019–2026 (USD MILLION) 196
TABLE 210 NORTH AMERICA: CARBON DIOXIDE INCUBATORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 197
TABLE 211 EUROPE: CARBON DIOXIDE INCUBATORS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 197
TABLE 212 ASIA PACIFIC: CARBON DIOXIDE INCUBATORS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 197
TABLE 213 LATIN AMERICA: CARBON DIOXIDE INCUBATORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 198
6.3.1.4 Centrifuges 198
6.3.1.4.1 Technological advances have enabled the development
of faster & compact centrifuges 198
TABLE 214 CENTRIFUGES OFFERED BY KEY MARKET PLAYERS 198
TABLE 215 CENTRIFUGES MARKET, BY REGION, 2019–2026 (USD MILLION) 199
TABLE 216 NORTH AMERICA: CENTRIFUGES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 199
TABLE 217 EUROPE: CENTRIFUGES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 200
TABLE 218 ASIA PACIFIC: CENTRIFUGES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 200
TABLE 219 LATIN AMERICA: CENTRIFUGES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 200
6.3.1.5 Autoclaves 201
6.3.1.5.1 Autoclaves sterilize equipment and supplies 201
TABLE 220 AUTOCLAVES MARKET, BY REGION, 2019–2026 (USD MILLION) 201
TABLE 221 NORTH AMERICA: AUTOCLAVES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 201
TABLE 222 EUROPE: AUTOCLAVES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 202
TABLE 223 ASIA PACIFIC: AUTOCLAVES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 202
TABLE 224 LATIN AMERICA: AUTOCLAVES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 202
6.3.1.6 Microscopes 203
6.3.1.6.1 Inverted microscopes are widely used in cell
culture processes 203
TABLE 225 MICROSCOPES MARKET, BY REGION, 2019–2026 (USD MILLION) 203
TABLE 226 NORTH AMERICA: MICROSCOPES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 203
TABLE 227 EUROPE: MICROSCOPES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 204
TABLE 228 ASIA PACIFIC: MICROSCOPES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 204
TABLE 229 LATIN AMERICA: MICROSCOPES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 204
6.3.1.7 Biosafety cabinets 205
6.3.1.7.1 Cabinets are classified into three classes based on
the type of protection offered 205
TABLE 230 BIOSAFETY CABINETS OFFERED BY KEY MARKET PLAYERS 205
TABLE 231 BIOSAFETY CABINETS MARKET, BY REGION, 2019–2026 (USD MILLION) 206
TABLE 232 NORTH AMERICA: BIOSAFETY CABINETS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 206
TABLE 233 EUROPE: BIOSAFETY CABINETS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 206
TABLE 234 ASIA PACIFIC: BIOSAFETY CABINETS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 207
TABLE 235 LATIN AMERICA: BIOSAFETY CABINETS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 207
6.3.1.8 Other supporting equipment 207
TABLE 236 OTHER SUPPORTING EQUIPMENT OFFERED BY KEY MARKET PLAYERS 208
TABLE 237 OTHER SUPPORTING EQUIPMENT MARKET, BY REGION,
2019–2026 (USD MILLION) 208
TABLE 238 NORTH AMERICA: OTHER SUPPORTING EQUIPMENT MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 208
TABLE 239 EUROPE: OTHER SUPPORTING EQUIPMENT MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 209
TABLE 240 ASIA PACIFIC: OTHER SUPPORTING EQUIPMENT MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 209
TABLE 241 LATIN AMERICA: OTHER SUPPORTING EQUIPMENT MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 209
6.3.2 BIOREACTORS 210
TABLE 242 BIOREACTORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 210
TABLE 243 BIOREACTORS MARKET, BY REGION, 2019–2026 (USD MILLION) 210
TABLE 244 NORTH AMERICA: BIOREACTORS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 210
TABLE 245 EUROPE: BIOREACTORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 211
TABLE 246 ASIA PACIFIC: BIOREACTORS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 211
TABLE 247 LATIN AMERICA: BIOREACTORS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 211
6.3.2.1.1 Bioreactors market, by application 212
TABLE 248 BIOREACTORS MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 212
6.3.2.2 Conventional bioreactors 212
6.3.2.2.1 Conventional bioreactors are widely used for
large-scale bioproduction 212
TABLE 249 CONVENTIONAL BIOREACTORS MARKET, BY REGION,
2019–2026 (USD MILLION) 212
TABLE 250 NORTH AMERICA: CONVENTIONAL BIOREACTORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 213
TABLE 251 EUROPE: CONVENTIONAL BIOREACTORS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 213
TABLE 252 ASIA PACIFIC: CONVENTIONAL BIOREACTORS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 213
TABLE 253 LATIN AMERICA: CONVENTIONAL BIOREACTORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 214
6.3.2.3 Single-use bioreactors 214
6.3.2.3.1 Convenience, ease of use, and flexibility are driving the demand for SUBs 214
TABLE 254 SINGLE-USE BIOREACTORS OFFERED BY KEY MARKET PLAYERS 214
TABLE 255 SINGLE-USE BIOREACTORS MARKET, BY REGION,
2019–2026 (USD MILLION) 215
TABLE 256 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 215
TABLE 257 EUROPE: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 215
TABLE 258 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 216
TABLE 259 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 216
6.3.3 STORAGE EQUIPMENT 216
TABLE 260 STORAGE EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION) 216
TABLE 261 STORAGE EQUIPMENT MARKET, BY REGION, 2019–2026 (USD MILLION) 217
TABLE 262 NORTH AMERICA: STORAGE EQUIPMENT MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 217
TABLE 263 EUROPE: STORAGE EQUIPMENT MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 217
TABLE 264 ASIA PACIFIC: STORAGE EQUIPMENT MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 218
TABLE 265 LATIN AMERICA: STORAGE EQUIPMENT MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 218
6.3.3.1 Refrigerators & freezers 218
6.3.3.1.1 Refrigerators & freezers are used for both short
and long-term storage 218
TABLE 266 REFRIGERATORS & FREEZERS MARKET, BY REGION,
2019–2026 (USD MILLION) 219
TABLE 267 NORTH AMERICA: REFRIGERATORS & FREEZERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 219
TABLE 268 EUROPE: REFRIGERATORS & FREEZERS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 220
TABLE 269 ASIA PACIFIC: REFRIGERATORS & FREEZERS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 220
TABLE 270 LATIN AMERICA: REFRIGERATORS & FREEZERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 220
6.3.3.2 Cryostorage systems 221
6.3.3.2.1 Benefits of the long-term preservation of cell cultures are driving segment growth 221
TABLE 271 CRYOSTORAGE SYSTEMS MARKET, BY REGION, 2019–2026 (USD MILLION) 221
TABLE 272 NORTH AMERICA: CRYOSTORAGE SYSTEMS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 222
TABLE 273 EUROPE: CRYOSTORAGE SYSTEMS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 222
TABLE 274 ASIA PACIFIC: CRYOSTORAGE SYSTEMS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 222
TABLE 275 LATIN AMERICA: CRYOSTORAGE SYSTEMS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 223
7 CELL CULTURE MARKET, BY APPLICATION 224
7.1 INTRODUCTION 225
TABLE 276 CELL CULTURE MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 225
7.2 BIOPHARMACEUTICAL PRODUCTION 225
TABLE 277 CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION,
BY REGION, 2019–2026 (USD MILLION) 226
TABLE 278 NORTH AMERICA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION) 226
TABLE 279 EUROPE: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION) 226
TABLE 280 ASIA PACIFIC: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION) 227
TABLE 281 LATIN AMERICA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION) 227
TABLE 282 CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION,
BY TYPE, 2019–2026 (USD MILLION) 227
7.2.1 MONOCLONAL ANTIBODY PRODUCTION 228
7.2.1.1 Growing number of mAb product candidates currently in development to drive the growth of this segment 228
TABLE 283 CELL CULTURE MARKET FOR MONOCLONAL ANTIBODY PRODUCTION,
BY REGION, 2019–2026 (USD MILLION) 228
TABLE 284 NORTH AMERICA: CELL CULTURE MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION) 229
TABLE 285 EUROPE: CELL CULTURE MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION) 229
TABLE 286 ASIA PACIFIC: CELL CULTURE MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION) 229
TABLE 287 LATIN AMERICA: CELL CULTURE MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION) 230
7.2.2 VACCINE PRODUCTION 230
7.2.2.1 Rising incidence of infectious diseases to drive the growth
of this segment 230
TABLE 288 CELL CULTURE MARKET FOR VACCINE PRODUCTION, BY REGION,
2019–2026 (USD MILLION) 231
TABLE 289 NORTH AMERICA: CELL CULTURE MARKET FOR VACCINE PRODUCTION,
BY COUNTRY, 2019–2026 (USD MILLION) 231
TABLE 290 EUROPE: CELL CULTURE MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION) 231
TABLE 291 ASIA PACIFIC: CELL CULTURE MARKET FOR VACCINE PRODUCTION,
BY COUNTRY, 2019–2026 (USD MILLION) 232
TABLE 292 LATIN AMERICA: CELL CULTURE MARKET FOR VACCINE PRODUCTION,
BY COUNTRY, 2019–2026 (USD MILLION) 232
7.2.3 OTHER THERAPEUTIC PROTEIN PRODUCTION 232
TABLE 293 CELL CULTURE MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION,
BY REGION, 2019–2026 (USD MILLION) 233
TABLE 294 NORTH AMERICA: CELL CULTURE MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION) 233
TABLE 295 EUROPE: CELL CULTURE MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION) 234
TABLE 296 ASIA PACIFIC: CELL CULTURE MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION) 234
TABLE 297 LATIN AMERICA: CELL CULTURE MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION) 235
7.3 DIAGNOSTICS 235
7.3.1 INCREASING RISK OF VIRAL INFECTIONS DRIVING THE GROWTH OF THIS SEGMENT 235
TABLE 298 CELL CULTURE MARKET FOR DIAGNOSTICS, BY REGION,
2019–2026 (USD MILLION) 235
TABLE 299 NORTH AMERICA: CELL CULTURE MARKET FOR DIAGNOSTICS, BY COUNTRY, 2019–2026 (USD MILLION) 236
TABLE 300 EUROPE: CELL CULTURE MARKET FOR DIAGNOSTICS, BY COUNTRY,
2019–2026 (USD MILLION) 236
TABLE 301 ASIA PACIFIC: CELL CULTURE MARKET FOR DIAGNOSTICS, BY COUNTRY, 2019–2026 (USD MILLION) 236
TABLE 302 LATIN AMERICA: CELL CULTURE MARKET FOR DIAGNOSTICS, BY COUNTRY, 2019–2026 (USD MILLION) 237
7.4 DRUG SCREENING & DEVELOPMENT 237
7.4.1 INCREASING ADOPTION OF CELL-BASED ASSAYS IN R&D ACTIVITIES
TO DRIVE THE GROWTH OF THIS SEGMENT 237
TABLE 303 CELL CULTURE MARKET FOR DRUG SCREENING & DEVELOPMENT,
BY REGION, 2019–2026 (USD MILLION) 237
TABLE 304 NORTH AMERICA: CELL CULTURE MARKET FOR DRUG SCREENING
& DEVELOPMENT, BY COUNTRY, 2019–2026 (USD MILLION) 238
TABLE 305 EUROPE: CELL CULTURE MARKET FOR DRUG SCREENING & DEVELOPMENT, BY COUNTRY, 2019–2026 (USD MILLION) 238
TABLE 306 ASIA PACIFIC: CELL CULTURE MARKET FOR DRUG SCREENING & DEVELOPMENT, BY COUNTRY, 2019–2026 (USD MILLION) 238
TABLE 307 LATIN AMERICA: CELL CULTURE MARKET FOR DRUG SCREENING & DEVELOPMENT, BY COUNTRY, 2019–2026 (USD MILLION) 239
7.5 TISSUE ENGINEERING & REGENERATIVE MEDICINE 239
TABLE 308 CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION) 240
TABLE 309 CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY REGION, 2019–2026 (USD MILLION) 240
TABLE 310 NORTH AMERICA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2019–2026 (USD MILLION) 240
TABLE 311 EUROPE: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2019–2026 (USD MILLION) 241
TABLE 312 ASIA PACIFIC: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2019–2026 (USD MILLION) 241
TABLE 313 LATIN AMERICA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2019–2026 (USD MILLION) 241
7.5.1 CELL & GENE THERAPY 242
7.5.1.1 Growing awareness of cell and gene therapy to drive the
growth of this segment 242
TABLE 314 CELL CULTURE MARKET FOR CELL & GENE THERAPY, BY REGION,
2019–2026 (USD MILLION) 243
TABLE 315 NORTH AMERICA: CELL CULTURE MARKET FOR CELL & GENE THERAPY,
BY COUNTRY, 2019–2026 (USD MILLION) 243
TABLE 316 EUROPE: CELL CULTURE MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2019–2026 (USD MILLION) 243
TABLE 317 ASIA PACIFIC: CELL CULTURE MARKET FOR CELL & GENE THERAPY,
BY COUNTRY, 2019–2026 (USD MILLION) 244
TABLE 318 LATIN AMERICA: CELL CULTURE MARKET FOR CELL & GENE THERAPY,
BY COUNTRY, 2019–2026 (USD MILLION) 244
7.5.2 OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS 244
TABLE 319 CELL CULTURE MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY REGION, 2019–2026 (USD MILLION) 245
TABLE 320 NORTH AMERICA: CELL CULTURE MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY,
2019–2026 (USD MILLION) 245
TABLE 321 EUROPE: CELL CULTURE MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY,
2019–2026 (USD MILLION) 245
TABLE 322 ASIA PACIFIC: CELL CULTURE MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY,
2019–2026 (USD MILLION) 246
TABLE 323 LATIN AMERICA: CELL CULTURE MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY,
2019–2026 (USD MILLION) 246
7.6 OTHER APPLICATIONS 246
TABLE 324 CELL CULTURE MARKET FOR OTHER APPLICATIONS, BY REGION,
2019–2026 (USD MILLION) 247
TABLE 325 NORTH AMERICA: CELL CULTURE MARKET FOR OTHER APPLICATIONS,
BY COUNTRY, 2019–2026 (USD MILLION) 247
TABLE 326 EUROPE: CELL CULTURE MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION) 247
TABLE 327 ASIA PACIFIC: CELL CULTURE MARKET FOR OTHER APPLICATIONS,
BY COUNTRY, 2019–2026 (USD MILLION) 248
TABLE 328 LATIN AMERICA: CELL CULTURE MARKET FOR OTHER APPLICATIONS,
BY COUNTRY, 2019–2026 (USD MILLION) 248
8 CELL CULTURE MARKET, BY END USER 249
8.1 INTRODUCTION 250
TABLE 329 CELL CULTURE MARKET, BY END USER, 2019–2026 (USD MILLION) 250
8.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 250
8.2.1 GROWING INVESTMENTS BY TOP MARKET PLAYERS TO DRIVE THE GROWTH OF THIS END-USER SEGMENT 250
TABLE 330 CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2019–2026 (USD MILLION) 251
TABLE 331 NORTH AMERICA: CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION) 251
TABLE 332 EUROPE: CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION) 252
TABLE 333 ASIA PACIFIC: CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION) 252
TABLE 334 LATIN AMERICA: CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION) 253
8.3 HOSPITALS & DIAGNOSTIC LABORATORIES 253
8.3.1 INCREASING APPLICATIONS OF CELL CULTURE FOR THE DIAGNOSIS OF VARIOUS DISEASES TO DRIVE THE GROWTH OF THIS SEGMENT 253
TABLE 335 CELL CULTURE MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES,
BY REGION, 2019–2026 (USD MILLION) 253
TABLE 336 NORTH AMERICA: CELL CULTURE MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2019–2026 (USD MILLION) 254
TABLE 337 EUROPE: CELL CULTURE MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2019–2026 (USD MILLION) 254
TABLE 338 ASIA PACIFIC: CELL CULTURE MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2019–2026 (USD MILLION) 254
TABLE 339 LATIN AMERICA: CELL CULTURE MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2019–2026 (USD MILLION) 255
8.4 RESEARCH & ACADEMIC INSTITUTES 255
8.4.1 INCREASING RESEARCH EFFORTS AND THE HIGH PREVALENCE OF CANCER TO DRIVE THE GROWTH OF THIS END-USER SEGMENT 255
TABLE 340 CELL CULTURE MARKET FOR RESEARCH & ACADEMIC INSTITUTES,
BY REGION, 2019–2026 (USD MILLION) 256
TABLE 341 NORTH AMERICA: CELL CULTURE MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2019–2026 (USD MILLION) 256
TABLE 342 EUROPE: CELL CULTURE MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2019–2026 (USD MILLION) 256
TABLE 343 ASIA PACIFIC: CELL CULTURE MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2019–2026 (USD MILLION) 257
TABLE 344 LATIN AMERICA: CELL CULTURE MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2019–2026 (USD MILLION) 257
8.5 OTHER END USERS 257
TABLE 345 CELL CULTURE MARKET FOR OTHER END USERS, BY REGION,
2019–2026 (USD MILLION) 258
TABLE 346 NORTH AMERICA: CELL CULTURE MARKET FOR OTHER END USERS,
BY COUNTRY, 2019–2026 (USD MILLION) 258
TABLE 347 EUROPE: CELL CULTURE MARKET FOR OTHER END USERS, BY COUNTRY, 2019–2026 (USD MILLION) 259
TABLE 348 ASIA PACIFIC: CELL CULTURE MARKET FOR OTHER END USERS, BY COUNTRY, 2019–2026 (USD MILLION) 259
TABLE 349 LATIN AMERICA: CELL CULTURE MARKET FOR OTHER END USERS,
BY COUNTRY, 2019–2026 (USD MILLION) 259
9 CELL CULTURE MARKET, BY REGION 260
9.1 INTRODUCTION 261
TABLE 350 CELL CULTURE MARKET, BY REGION, 2019–2026 (USD MILLION) 261
9.2 NORTH AMERICA 261
FIGURE 26 NORTH AMERICA: CELL CULTURE MARKET SNAPSHOT 262
TABLE 351 NORTH AMERICA: CELL CULTURE MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 263
TABLE 352 NORTH AMERICA: CELL CULTURE MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 263
TABLE 353 NORTH AMERICA: CELL CULTURE CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 263
TABLE 354 NORTH AMERICA: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 264
TABLE 355 NORTH AMERICA: CELL CULTURE MEDIA MARKET, BY TYPE,
2019–2026 (USD MILLION) 264
TABLE 356 NORTH AMERICA: CELL CULTURE REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 265
TABLE 357 NORTH AMERICA: CELL CULTURE SERA MARKET, BY TYPE,
2019–2026 (USD MILLION) 265
TABLE 358 NORTH AMERICA: CELL CULTURE VESSELS MARKET, BY TYPE,
2019–2026 (USD MILLION) 266
TABLE 359 NORTH AMERICA: CELL CULTURE EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 266
TABLE 360 NORTH AMERICA: CELL CULTURE SUPPORTING EQUIPMENT MARKET,
BY TYPE, 2019–2026 (USD MILLION) 267
TABLE 361 NORTH AMERICA: BIOREACTORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 267
TABLE 362 NORTH AMERICA: CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION) 267
TABLE 363 NORTH AMERICA: CELL CULTURE MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 268
TABLE 364 NORTH AMERICA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION) 268
TABLE 365 NORTH AMERICA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION) 268
TABLE 366 NORTH AMERICA: CELL CULTURE MARKET, BY END USER,
2019–2026 (USD MILLION) 269
9.2.1 US 269
9.2.1.1 Well-established pharmaceutical & biotechnology sector driving market growth in the US 269
TABLE 367 US: CELL CULTURE MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 270
TABLE 368 US: CELL CULTURE CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 270
TABLE 369 US: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 270
TABLE 370 US: CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION) 271
TABLE 371 US: CELL CULTURE REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 271
TABLE 372 US: CELL CULTURE SERA MARKET, BY TYPE, 2019–2026 (USD MILLION) 272
TABLE 373 US: CELL CULTURE VESSELS MARKET, BY TYPE, 2019–2026 (USD MILLION) 272
TABLE 374 US: CELL CULTURE EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 272
TABLE 375 US: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 273
TABLE 376 US: BIOREACTORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 273
TABLE 377 US: CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 273
TABLE 378 US: CELL CULTURE MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 274
TABLE 379 US: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION,
BY TYPE, 2019–2026 (USD MILLION) 274
TABLE 380 US: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION) 274
TABLE 381 US: CELL CULTURE MARKET, BY END USER, 2019–2026 (USD MILLION) 275
9.2.2 CANADA 275
9.2.2.1 Advancements in the field of regenerative medicine to drive market growth in Canada 275
TABLE 382 CANADA: CELL CULTURE MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 276
TABLE 383 CANADA: CELL CULTURE CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 276
TABLE 384 CANADA: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 276
TABLE 385 CANADA: CELL CULTURE MEDIA MARKET, BY TYPE,
2019–2026 (USD MILLION) 277
TABLE 386 CANADA: CELL CULTURE REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 277
TABLE 387 CANADA: CELL CULTURE SERA MARKET, BY TYPE,
2019–2026 (USD MILLION) 278
TABLE 388 CANADA: CELL CULTURE VESSELS MARKET, BY TYPE,
2019–2026 (USD MILLION) 278
TABLE 389 CANADA: CELL CULTURE EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 278
TABLE 390 CANADA: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 279
TABLE 391 CANADA: BIOREACTORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 279
TABLE 392 CANADA: CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 279
TABLE 393 CANADA: CELL CULTURE MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 280
TABLE 394 CANADA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION) 280
TABLE 395 CANADA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION) 280
TABLE 396 CANADA: CELL CULTURE MARKET, BY END USER,
2019–2026 (USD MILLION) 281
9.3 EUROPE 281
TABLE 397 EUROPE: CELL CULTURE MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 282
TABLE 398 EUROPE: CELL CULTURE MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 282
TABLE 399 EUROPE: CELL CULTURE CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 282
TABLE 400 EUROPE: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 283
TABLE 401 EUROPE: CELL CULTURE MEDIA MARKET, BY TYPE,
2019–2026 (USD MILLION) 283
TABLE 402 EUROPE: CELL CULTURE REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 284
TABLE 403 EUROPE: CELL CULTURE SERA MARKET, BY TYPE,
2019–2026 (USD MILLION) 284
TABLE 404 EUROPE: CELL CULTURE VESSELS MARKET, BY TYPE,
2019–2026 (USD MILLION) 285
TABLE 405 EUROPE: CELL CULTURE EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 285
TABLE 406 EUROPE: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 285
TABLE 407 EUROPE: BIOREACTORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 286
TABLE 408 EUROPE: CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 286
TABLE 409 EUROPE: CELL CULTURE MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 286
TABLE 410 EUROPE: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION) 287
TABLE 411 EUROPE: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION) 287
TABLE 412 EUROPE: CELL CULTURE MARKET, BY END USER, 2019–2026 (USD MILLION) 287
9.3.1 GERMANY 288
9.3.1.1 Increasing R&D investments by various key players and funding from government organizations to drive market growth 288
TABLE 413 GERMANY: CELL CULTURE MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 288
TABLE 414 GERMANY: CELL CULTURE CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 289
TABLE 415 GERMANY: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 289
TABLE 416 GERMANY: CELL CULTURE MEDIA MARKET, BY TYPE,
2019–2026 (USD MILLION) 289
TABLE 417 GERMANY: CELL CULTURE REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 290
TABLE 418 GERMANY: CELL CULTURE SERA MARKET, BY TYPE,
2019–2026 (USD MILLION) 290
TABLE 419 GERMANY: CELL CULTURE VESSELS MARKET, BY TYPE,
2019–2026 (USD MILLION) 291
TABLE 420 GERMANY: CELL CULTURE EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 291
TABLE 421 GERMANY: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION) 291
TABLE 422 GERMANY: BIOREACTORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 292
TABLE 423 GERMANY: CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 292
TABLE 424 GERMANY: CELL CULTURE MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 292
TABLE 425 GERMANY: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION) 293
TABLE 426 GERMANY: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION) 293
TABLE 427 GERMANY: CELL CULTURE MARKET, BY END USER,
2019–2026 (USD MILLION) 293
9.3.2 UK 294
9.3.2.1 Growth in the life science industry to drive the cell culture
market in the UK 294
TABLE 428 UK: CELL CULTURE MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 294
TABLE 429 UK: CELL CULTURE CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 295
TABLE 430 UK: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 295
TABLE 431 UK: CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION) 295
TABLE 432 UK: CELL CULTURE REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 296
TABLE 433 UK: CELL CULTURE SERA MARKET, BY TYPE, 2019–2026 (USD MILLION) 296
TABLE 434 UK: CELL CULTURE VESSELS MARKET, BY TYPE, 2019–2026 (USD MILLION) 297
TABLE 435 UK: CELL CULTURE EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 297
TABLE 436 UK: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 297
TABLE 437 UK: BIOREACTORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 298
TABLE 438 UK: CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 298
TABLE 439 UK: CELL CULTURE MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 298
TABLE 440 UK: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION,
BY TYPE, 2019–2026 (USD MILLION) 299
TABLE 441 UK: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION) 299
TABLE 442 UK: CELL CULTURE MARKET, BY END USER, 2019–2026 (USD MILLION) 299
9.3.3 FRANCE 300
9.3.3.1 Support from government and private investors to drive market growth in France 300
TABLE 443 FRANCE: CELL CULTURE MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 300
TABLE 444 FRANCE: CELL CULTURE CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 301
TABLE 445 FRANCE: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 301
TABLE 446 FRANCE: CELL CULTURE MEDIA MARKET, BY TYPE,
2019–2026 (USD MILLION) 301
TABLE 447 FRANCE: CELL CULTURE REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 302
TABLE 448 FRANCE: CELL CULTURE SERA MARKET, BY TYPE, 2019–2026 (USD MILLION) 302
TABLE 449 FRANCE: CELL CULTURE VESSELS MARKET, BY TYPE,
2019–2026 (USD MILLION) 303
TABLE 450 FRANCE: CELL CULTURE EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 303
TABLE 451 FRANCE: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 303
TABLE 452 FRANCE: BIOREACTORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 304
TABLE 453 FRANCE: CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 304
TABLE 454 FRANCE: CELL CULTURE MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 304
TABLE 455 FRANCE: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION) 305
TABLE 456 FRANCE: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION) 305
TABLE 457 FRANCE: CELL CULTURE MARKET, BY END USER, 2019–2026 (USD MILLION) 305
9.3.4 ITALY 306
9.3.4.1 Italy is a leading life science research hub in Europe 306
TABLE 458 ITALY: CELL CULTURE MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 307
TABLE 459 ITALY: CELL CULTURE CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 307
TABLE 460 ITALY: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 307
TABLE 461 ITALY: CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION) 308
TABLE 462 ITALY: CELL CULTURE REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 308
TABLE 463 ITALY: CELL CULTURE SERA MARKET, BY TYPE, 2019–2026 (USD MILLION) 309
TABLE 464 ITALY: CELL CULTURE VESSELS MARKET, BY TYPE,
2019–2026 (USD MILLION) 309
TABLE 465 ITALY: CELL CULTURE EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 309
TABLE 466 ITALY: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 310
TABLE 467 ITALY: BIOREACTORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 310
TABLE 468 ITALY: CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 310
TABLE 469 ITALY: CELL CULTURE MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 311
TABLE 470 ITALY: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION,
BY TYPE, 2019–2026 (USD MILLION) 311
TABLE 471 ITALY: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION) 311
TABLE 472 ITALY: CELL CULTURE MARKET, BY END USER, 2019–2026 (USD MILLION) 312
9.3.5 SPAIN 312
9.3.5.1 Increasing funding from private and public organizations to
aid market growth in Spain 312
TABLE 473 SPAIN: CELL CULTURE MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 313
TABLE 474 SPAIN: CELL CULTURE CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 313
TABLE 475 SPAIN: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 313
TABLE 476 SPAIN: CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION) 314
TABLE 477 SPAIN: CELL CULTURE REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 314
TABLE 478 SPAIN: CELL CULTURE SERA MARKET, BY TYPE, 2019–2026 (USD MILLION) 315
TABLE 479 SPAIN: CELL CULTURE VESSELS MARKET, BY TYPE,
2019–2026 (USD MILLION) 315
TABLE 480 SPAIN: CELL CULTURE EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 315
TABLE 481 SPAIN: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 316
TABLE 482 SPAIN: BIOREACTORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 316
TABLE 483 SPAIN: CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 316
TABLE 484 SPAIN: CELL CULTURE MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 317
TABLE 485 SPAIN: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION,
BY TYPE, 2019–2026 (USD MILLION) 317
TABLE 486 SPAIN: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION) 317
TABLE 487 SPAIN: CELL CULTURE MARKET, BY END USER, 2019–2026 (USD MILLION) 318
9.3.6 REST OF EUROPE 318
TABLE 488 ROE: CELL CULTURE MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 318
TABLE 489 ROE: CELL CULTURE CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 319
TABLE 490 ROE: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 319
TABLE 491 ROE: CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION) 319
TABLE 492 ROE: CELL CULTURE REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 320
TABLE 493 ROE: CELL CULTURE SERA MARKET, BY TYPE, 2019–2026 (USD MILLION) 320
TABLE 494 ROE: CELL CULTURE VESSELS MARKET, BY TYPE, 2019–2026 (USD MILLION) 321
TABLE 495 ROE: CELL CULTURE EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 321
TABLE 496 ROE: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 321
TABLE 497 ROE: BIOREACTORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 322
TABLE 498 ROE: CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 322
TABLE 499 ROE: CELL CULTURE MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 322
TABLE 500 ROE: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION,
BY TYPE, 2019–2026 (USD MILLION) 323
TABLE 501 ROE: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION) 323
TABLE 502 ROE: CELL CULTURE MARKET, BY END USER, 2019–2026 (USD MILLION) 323
9.4 ASIA PACIFIC 324
FIGURE 27 ASIA PACIFIC: CELL CULTURE MARKET SNAPSHOT 325
TABLE 503 ASIA PACIFIC: CELL CULTURE MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 326
TABLE 504 ASIA PACIFIC: CELL CULTURE MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 326
TABLE 505 ASIA PACIFIC: CELL CULTURE CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 326
TABLE 506 ASIA PACIFIC: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 327
TABLE 507 ASIA PACIFIC: CELL CULTURE MEDIA MARKET, BY TYPE,
2019–2026 (USD MILLION) 327
TABLE 508 ASIA PACIFIC: CELL CULTURE REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 328
TABLE 509 ASIA PACIFIC: CELL CULTURE SERA MARKET, BY TYPE,
2019–2026 (USD MILLION) 328
TABLE 510 ASIA PACIFIC: CELL CULTURE VESSELS MARKET, BY TYPE,
2019–2026 (USD MILLION) 329
TABLE 511 ASIA PACIFIC: CELL CULTURE EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 329
TABLE 512 ASIA PACIFIC: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION) 329
TABLE 513 ASIA PACIFIC: BIOREACTORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 330
TABLE 514 ASIA PACIFIC: CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION) 330
TABLE 515 ASIA PACIFIC: CELL CULTURE MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 330
TABLE 516 ASIA PACIFIC: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION) 331
TABLE 517 ASIA PACIFIC: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION) 331
TABLE 518 ASIA PACIFIC: CELL CULTURE MARKET, BY END USER,
2019–2026 (USD MILLION) 331
9.4.1 CHINA 332
9.4.1.1 China to register the highest growth rate in the Asia Pacific cell culture market during the forecast period 332
TABLE 519 CHINA: CELL CULTURE MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 333
TABLE 520 CHINA: CELL CULTURE CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 333
TABLE 521 CHINA: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 333
TABLE 522 CHINA: CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION) 334
TABLE 523 CHINA: CELL CULTURE REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 334
TABLE 524 CHINA: CELL CULTURE SERA MARKET, BY TYPE, 2019–2026 (USD MILLION) 335
TABLE 525 CHINA: CELL CULTURE VESSELS MARKET, BY TYPE,
2019–2026 (USD MILLION) 335
TABLE 526 CHINA: CELL CULTURE EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 335
TABLE 527 CHINA: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 336
TABLE 528 CHINA: BIOREACTORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 336
TABLE 529 CHINA: CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 336
TABLE 530 CHINA: CELL CULTURE MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 337
TABLE 531 CHINA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION,
BY TYPE, 2019–2026 (USD MILLION) 337
TABLE 532 CHINA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION) 337
TABLE 533 CHINA: CELL CULTURE MARKET, BY END USER, 2019–2026 (USD MILLION) 338
9.4.2 JAPAN 338
9.4.2.1 Strategic developments by companies to drive the market for
cell culture in Japan 338
TABLE 534 JAPAN: CELL CULTURE MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 339
TABLE 535 JAPAN: CELL CULTURE CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 339
TABLE 536 JAPAN: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 339
TABLE 537 JAPAN: CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION) 340
TABLE 538 JAPAN: CELL CULTURE REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 340
TABLE 539 JAPAN: CELL CULTURE SERA MARKET, BY TYPE, 2019–2026 (USD MILLION) 341
TABLE 540 JAPAN: CELL CULTURE VESSELS MARKET, BY TYPE,
2019–2026 (USD MILLION) 341
TABLE 541 JAPAN: CELL CULTURE EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 341
TABLE 542 JAPAN: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 342
TABLE 543 JAPAN: BIOREACTORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 342
TABLE 544 JAPAN: CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 342
TABLE 545 JAPAN: CELL CULTURE MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 343
TABLE 546 JAPAN: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION,
BY TYPE, 2019–2026 (USD MILLION) 343
TABLE 547 JAPAN: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION) 343
TABLE 548 JAPAN: CELL CULTURE MARKET, BY END USER, 2019–2026 (USD MILLION) 344
9.4.3 INDIA 344
9.4.3.1 Favorable government regulations and support to drive the cell culture market in India 344
TABLE 549 INDIA: CELL CULTURE MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 345
TABLE 550 INDIA: CELL CULTURE CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 345
TABLE 551 INDIA: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 345
TABLE 552 INDIA: CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION) 346
TABLE 553 INDIA: CELL CULTURE REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 346
TABLE 554 INDIA: CELL CULTURE SERA MARKET, BY TYPE, 2019–2026 (USD MILLION) 347
TABLE 555 INDIA: CELL CULTURE VESSELS MARKET, BY TYPE,
2019–2026 (USD MILLION) 347
TABLE 556 INDIA: CELL CULTURE EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 347
TABLE 557 INDIA: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 348
TABLE 558 INDIA: BIOREACTORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 348
TABLE 559 INDIA: CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 348
TABLE 560 INDIA: CELL CULTURE MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 349
TABLE 561 INDIA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION,
BY TYPE, 2019–2026 (USD MILLION) 349
TABLE 562 INDIA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION) 349
TABLE 563 INDIA: CELL CULTURE MARKET, BY END USER, 2019–2026 (USD MILLION) 350
9.4.4 SOUTH KOREA 350
9.4.4.1 Increasing pharmaceutical and biotech R&D investment to drive the cell culture market in South Korea 350
TABLE 564 SOUTH KOREA: CELL CULTURE MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 351
TABLE 565 SOUTH KOREA: CELL CULTURE CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 351
TABLE 566 SOUTH KOREA: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 351
TABLE 567 SOUTH KOREA: CELL CULTURE MEDIA MARKET, BY TYPE,
2019–2026 (USD MILLION) 352
TABLE 568 SOUTH KOREA: CELL CULTURE REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 352
TABLE 569 SOUTH KOREA: CELL CULTURE SERA MARKET, BY TYPE,
2019–2026 (USD MILLION) 353
TABLE 570 SOUTH KOREA: CELL CULTURE VESSELS MARKET, BY TYPE,
2019–2026 (USD MILLION) 353
TABLE 571 SOUTH KOREA: CELL CULTURE EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 354
TABLE 572 SOUTH KOREA: CELL CULTURE SUPPORTING EQUIPMENT MARKET,
BY TYPE, 2019–2026 (USD MILLION) 354
TABLE 573 SOUTH KOREA: BIOREACTORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 354
TABLE 574 SOUTH KOREA: CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION) 355
TABLE 575 SOUTH KOREA: CELL CULTURE MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 355
TABLE 576 SOUTH KOREA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION) 355
TABLE 577 SOUTH KOREA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION) 356
TABLE 578 SOUTH KOREA: CELL CULTURE MARKET, BY END USER,
2019–2026 (USD MILLION) 356
9.4.5 REST OF ASIA PACIFIC 356
TABLE 579 ROAPAC: CELL CULTURE MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 357
TABLE 580 ROAPAC: CELL CULTURE CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 357
TABLE 581 ROAPAC: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 357
TABLE 582 ROAPAC: CELL CULTURE MEDIA MARKET, BY TYPE,
2019–2026 (USD MILLION) 358
TABLE 583 ROAPAC: CELL CULTURE REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 358
TABLE 584 ROAPAC: CELL CULTURE SERA MARKET, BY TYPE,
2019–2026 (USD MILLION) 359
TABLE 585 ROAPAC: CELL CULTURE VESSELS MARKET, BY TYPE,
2019–2026 (USD MILLION) 359
TABLE 586 ROAPAC: CELL CULTURE EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 359
TABLE 587 ROAPAC: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 360
TABLE 588 ROAPAC: BIOREACTORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 360
TABLE 589 ROAPAC: CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 360
TABLE 590 ROAPAC: CELL CULTURE MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 361
TABLE 591 ROAPAC: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION) 361
TABLE 592 ROAPAC: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION) 361
TABLE 593 ROAPAC: CELL CULTURE MARKET, BY END USER, 2019–2026 (USD MILLION) 362
9.5 LATIN AMERICA 362
TABLE 594 LATIN AMERICA: CELL CULTURE MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 362
TABLE 595 LATIN AMERICA: CELL CULTURE MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 363
TABLE 596 LATIN AMERICA: CELL CULTURE CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 363
TABLE 597 LATIN AMERICA: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 363
TABLE 598 LATIN AMERICA: CELL CULTURE MEDIA MARKET, BY TYPE,
2019–2026 (USD MILLION) 364
TABLE 599 LATIN AMERICA: CELL CULTURE REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 364
TABLE 600 LATIN AMERICA: CELL CULTURE SERA MARKET, BY TYPE,
2019–2026 (USD MILLION) 365
TABLE 601 LATIN AMERICA: CELL CULTURE VESSELS MARKET, BY TYPE,
2019–2026 (USD MILLION) 365
TABLE 602 LATIN AMERICA: CELL CULTURE EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 365
TABLE 603 LATIN AMERICA: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION) 366
TABLE 604 LATIN AMERICA: BIOREACTORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 366
TABLE 605 LATIN AMERICA: CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION) 366
TABLE 606 LATIN AMERICA: CELL CULTURE MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 367
TABLE 607 LATIN AMERICA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION) 367
TABLE 608 LATIN AMERICA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION) 367
TABLE 609 LATIN AMERICA: CELL CULTURE MARKET, BY END USER,
2019–2026 (USD MILLION) 368
9.5.1 BRAZIL 368
9.5.1.1 Increasing healthcare spending on biologics and life science research to drive market growth in Brazil 368
TABLE 610 BRAZIL: CELL CULTURE MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 368
TABLE 611 BRAZIL: CELL CULTURE CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 369
TABLE 612 BRAZIL: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 369
TABLE 613 BRAZIL: CELL CULTURE MEDIA MARKET, BY TYPE,
2019–2026 (USD MILLION) 369
TABLE 614 BRAZIL: CELL CULTURE REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 370
TABLE 615 BRAZIL: CELL CULTURE SERA MARKET, BY TYPE, 2019–2026 (USD MILLION) 370
TABLE 616 BRAZIL: CELL CULTURE VESSELS MARKET, BY TYPE,
2019–2026 (USD MILLION) 371
TABLE 617 BRAZIL: CELL CULTURE EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 371
TABLE 618 BRAZIL: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 371
TABLE 619 BRAZIL: BIOREACTORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 372
TABLE 620 BRAZIL: CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 372
TABLE 621 BRAZIL: CELL CULTURE MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 372
TABLE 622 BRAZIL: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION) 373
TABLE 623 BRAZIL: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION) 373
TABLE 624 BRAZIL: CELL CULTURE MARKET, BY END USER, 2019–2026 (USD MILLION) 373
9.5.2 MEXICO 374
9.5.2.1 Growth in pharmaceutical manufacturing to drive R&D investments for cell culture in Mexico 374
TABLE 625 MEXICO: CELL CULTURE MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 374
TABLE 626 MEXICO: CELL CULTURE CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 374
TABLE 627 MEXICO: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 375
TABLE 628 MEXICO: CELL CULTURE MEDIA MARKET, BY TYPE,
2019–2026 (USD MILLION) 375
TABLE 629 MEXICO: CELL CULTURE REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 376
TABLE 630 MEXICO: CELL CULTURE SERA MARKET, BY TYPE, 2019–2026 (USD MILLION) 376
TABLE 631 MEXICO: CELL CULTURE VESSELS MARKET, BY TYPE,
2019–2026 (USD MILLION) 377
TABLE 632 MEXICO: CELL CULTURE EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 377
TABLE 633 MEXICO: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 377
TABLE 634 MEXICO: BIOREACTORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 378
TABLE 635 MEXICO: CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 378
TABLE 636 MEXICO: CELL CULTURE MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 378
TABLE 637 MEXICO: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION) 379
TABLE 638 MEXICO: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION) 379
TABLE 639 MEXICO: CELL CULTURE MARKET, BY END USER, 2019–2026 (USD MILLION) 379
9.5.3 REST OF LATIN AMERICA 380
TABLE 640 ROLATAM: CELL CULTURE MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 380
TABLE 641 ROLATAM: CELL CULTURE CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 380
TABLE 642 ROLATAM: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 381
TABLE 643 ROLATAM: CELL CULTURE MEDIA MARKET, BY TYPE,
2019–2026 (USD MILLION) 381
TABLE 644 ROLATAM: CELL CULTURE REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 382
TABLE 645 ROLATAM: CELL CULTURE SERA MARKET, BY TYPE,
2019–2026 (USD MILLION) 382
TABLE 646 ROLATAM: CELL CULTURE VESSELS MARKET, BY TYPE,
2019–2026 (USD MILLION) 383
TABLE 647 ROLATAM: CELL CULTURE EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 383
TABLE 648 ROLATAM: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION) 383
TABLE 649 ROLATAM: BIOREACTORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 384
TABLE 650 ROLATAM: CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 384
TABLE 651 ROLATAM: CELL CULTURE MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 384
TABLE 652 ROLATAM: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION) 385
TABLE 653 ROLATAM: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION) 385
TABLE 654 ROLATAM: CELL CULTURE MARKET, BY END USER,
2019–2026 (USD MILLION) 385
9.6 MIDDLE EAST AND AFRICA 386
9.6.1 INCREASING R&D FUNDING FOR STEM CELL THERAPY DRIVING MARKET GROWTH IN MEA 386
TABLE 655 MEA: CELL CULTURE MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 386
TABLE 656 MEA: CELL CULTURE CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 387
TABLE 657 MEA: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 387
TABLE 658 MEA: CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION) 387
TABLE 659 MEA: CELL CULTURE REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 388
TABLE 660 MEA: CELL CULTURE SERA MARKET, BY TYPE, 2019–2026 (USD MILLION) 388
TABLE 661 MEA: CELL CULTURE VESSELS MARKET, BY TYPE, 2019–2026 (USD MILLION) 389
TABLE 662 MEA: CELL CULTURE EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 389
TABLE 663 MEA: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 389
TABLE 664 MEA: BIOREACTORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 390
TABLE 665 MEA: CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 390
TABLE 666 MEA: CELL CULTURE MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 390
TABLE 667 MEA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION,
BY TYPE, 2019–2026 (USD MILLION) 391
TABLE 668 MEA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION) 391
TABLE 669 MEA: CELL CULTURE MARKET, BY END USER, 2019–2026 (USD MILLION) 391
10 COMPETITIVE LANDSCAPE 392
10.1 OVERVIEW 392
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 392
FIGURE 28 KEY DEVELOPMENTS IN THE CELL CULTURE MARKET, 2019–2022 393
10.3 MARKET SHARE ANALYSIS 394
FIGURE 29 CELL CULTURE MARKET: MARKET SHARE ANALYSIS, BY KEY PLAYER, 2020 394
TABLE 670 CELL CULTURE MARKET: DEGREE OF COMPETITION 394
10.4 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS 395
FIGURE 30 REVENUE SHARE ANALYSIS OF TOP PLAYERS IN THE CELL CULTURE
MARKET, 2018–2020 395
10.5 COMPANY EVALUATION QUADRANT 396
10.5.1 STARS 396
10.5.2 EMERGING LEADERS 396
10.5.3 PERVASIVE PLAYERS 396
10.5.4 PARTICIPANTS 396
FIGURE 31 CELL CULTURE MARKET: COMPANY EVALUATION QUADRANT, 2020 397
10.6 COMPANY EVALUATION QUADRANT: START-UPS/SMES 397
10.6.1 PROGRESSIVE COMPANIES 397
10.6.2 STARTING BLOCKS 398
10.6.3 RESPONSIVE COMPANIES 398
10.6.4 DYNAMIC COMPANIES 398
FIGURE 32 CELL CULTURE MARKET: COMPANY EVALUATION QUADRANT
FOR START-UPS/SMES, 2020 398
10.7 PRODUCT FOOTPRINT OF COMPANIES 399
TABLE 671 PRODUCT PORTFOLIO ANALYSIS: CELL CULTURE MARKET (2020) 399
10.8 REGIONAL FOOTPRINT OF COMPANY 400
TABLE 672 REGIONAL FOOTPRINT OF COMPANIES: CELL CULTURE MARKET (2020) 400
10.9 COMPETITIVE SCENARIO 401
TABLE 673 PRODUCT LAUNCHES 401
TABLE 674 DEALS 401
TABLE 675 EXPANSIONS 402
11 COMPANY PROFILES 403
11.1 KEY PLAYERS 403
(Business Overview, Products Offered, Recent Developments, Deals, MnM view, Key strengths/right to win, Strategic choices made, Weakness/competitive threats)*
11.1.1 THERMO FISHER SCIENTIFIC, INC. 403
TABLE 676 THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW 403
FIGURE 33 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2020) 404
11.1.2 DANAHER CORPORATION 412
TABLE 677 DANAHER CORPORATION: BUSINESS OVERVIEW 412
FIGURE 34 DANAHER CORPORATION: COMPANY SNAPSHOT (2020) 413
11.1.3 MERCK KGAA 420
TABLE 678 MERCK KGAA: BUSINESS OVERVIEW 420
FIGURE 35 MERCK KGAA: COMPANY SNAPSHOT (2020) 421
11.1.4 SARTORIUS AG 426
TABLE 679 SARTORIUS AG: BUSINESS OVERVIEW 426
FIGURE 36 SARTORIUS AG: COMPANY SNAPSHOT (2020) 427
11.1.5 CORNING INCORPORATED 432
TABLE 680 CORNING INCORPORATED: BUSINESS OVERVIEW 432
FIGURE 37 CORNING INCORPORATED: COMPANY SNAPSHOT (2020) 433
11.1.6 EPPENDORF AG 438
TABLE 681 EPPENDORF AG: BUSINESS OVERVIEW 438
FIGURE 38 EPPENDORF AG: COMPANY SNAPSHOT (2020) 439
11.1.7 FUJIFILM IRVINE SCIENTIFIC, INC. (ACQUIRED BY FUJIFILM HOLDINGS CORPORATION) 442
TABLE 682 FUJIFILM HOLDINGS CORPORATION: BUSINESS OVERVIEW 442
FIGURE 39 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT (2020) 443
11.1.8 LONZA GROUP AG 446
TABLE 683 LONZA GROUP AG: BUSINESS OVERVIEW 446
FIGURE 40 LONZA GROUP AG: COMPANY SNAPSHOT (2020) 447
11.1.9 AGILENT TECHNOLOGIES, INC. 450
TABLE 684 AGILENT TECHNOLOGIES, INC.: BUSINESS OVERVIEW 450
FIGURE 41 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2020) 451
11.1.10 GETINGE AB 453
TABLE 685 GETINGE AB: BUSINESS OVERVIEW 453
FIGURE 42 GETINGE AB: COMPANY SNAPSHOT (2020) 454
11.1.11 BECTON, DICKINSON AND COMPANY (BD) 456
TABLE 686 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW 456
FIGURE 43 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2020) 457
11.1.12 MILTENYI BIOTEC 460
TABLE 687 MILTENYI BIOTEC: BUSINESS OVERVIEW 460
11.1.13 HIMEDIA LABORATORIES 463
TABLE 688 HIMEDIA LABORATORIES: BUSINESS OVERVIEW 463
11.1.14 STEMCELL TECHNOLOGIES INC. 469
TABLE 689 STEMCELL TECHNOLOGIES, INC: BUSINESS OVERVIEW 469
11.1.15 SOLIDA BIOTECH GMBH 472
TABLE 690 SOLIDA BIOTECH GMBH: BUSINESS OVERVIEW 472
*Details on Business Overview, Products Offered, Recent Developments, Deals, MnM view, Key strengths/right to win, Strategic choices made, Weakness/competitive threats might not be captured in case of unlisted companies.
11.2 OTHER PLAYERS 474
11.2.1 CAISSON LABORATORIES INC. 474
11.2.2 PROMOCELL GMBH 475
11.2.3 INVIVOGEN 476
11.2.4 PAN-BIOTECH GMBH 477
11.2.5 CELLEXUS 478
11.2.6 MEISSNER FILTRATION PRODUCTS, INC. 478
11.2.7 ADOLF KÜHNER AG 479
11.2.8 SERACARE LIFE SCIENCES INC. 480
11.2.9 ANGUS CHEMICAL COMPANY 480
11.2.10 BIOSPHERIX, LTD. 481
12 APPENDIX 482
12.1 DISCUSSION GUIDE 482
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 486
12.3 AVAILABLE CUSTOMIZATIONS 488
12.4 RELATED REPORTS 489
12.5 AUTHOR DETAILS 490
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（バイオ薬物）の最新刊レポート
MarketsandMarkets 社の最新刊レポート
本レポートと同じKEY WORD（diagnostics）の最新刊レポート
よくあるご質問MarketsandMarkets社はどのような調査会社ですか?マーケッツアンドマーケッツ（MarketsandMarkets）は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/10/04 10:27 147.72 円 163.39 円 196.69 円 |
